Browse News
Filter News
Found 7 articles
-
After the FDA released draft guidance on increasing diversity in clinical trials, companies have been left to figure out the details. Here’s what experts say is working.
-
Curavit Raises $5 Million in Series A Funding to Accelerate Growth in Digital Therapeutics Clinical Research
11/14/2022
Curavit Clinical Research today announced it raised $5 million in Series A funding to accelerate its growing portfolio of research in the global digital therapeutics (DTx) market (projected to grow at a CAGR of 31.4% through 2026).
-
ixlayer Partners with Curavit to Enable Convenient Patient Medical Testing Services for Decentralized Clinical Trials
9/6/2022
Curavit Clinical Research, a virtual contract research organization (VCRO), has entered into a long-term partnership with ixlayer to provide easy access to clinical-grade diagnostic lab testing for decentralized clinical trials (DCTs).
-
Swing Therapeutics Selects Curavit to Provide Virtual Trial Site Services for Novel Digital Therapeutic Study for Fibromyalgia
6/28/2022
Curavit Clinical Research, a virtual contract research organization (VCRO), has been selected by digital therapeutics company, Swing Therapeutics, to be a virtual site for its pivotal trial of an investigational digital therapeutic (DTx) for fibromyalgia.
-
Beech Tree Labs selects Curavit Clinical Research for fully virtual COVID-19 clinical trial
9/18/2020
Beechtree Labs has chosen Curavit Clinical Research for a fully decentralized clinical trial to investigate a promising Covid-19 therapy.
-
Curavit Clinical Research and eMoyo USA, LLC Partner to Deliver High-Quality Home-Based Audiometric Data for Virtual Clinical Trials.
9/9/2020
Curavit Clinical Research, a virtual research organization, and eMoyo USA, LLC, the USA representative of eMoyo, a global leader in healthcare technology, announced a partnership to pave the way for hearing research studies to continue during the COVID-19 pandemic.
-
Curavit Clinical Research officially launches with a focus on virtual trials
2/18/2020
Industry veterans Joel Morse and Dave Hanaman announce the formation of a company to lead into the future of clinical trials